Skip to main content
Premium Trial:

Request an Annual Quote

Biocept: Michael Dugan

Biocept has appointed Michael Dugan as chief medical officer and medical director, responsible for medical policy decision-making and operations of Biocept's CLIA-certified laboratory. Dugan has more than 25 years of industry experience, most recently as president and CEO of professional advisory group practice MCDXI Medical Diagnostics International. Before that, he was senior medical advisor and chief medical officer of Clinical Genomics. He has also served as senior VP of clinical development and medical affairs at Exact Sciences, medical director at Quest Diagnostics Nichols Institute, chief medical officer at BioTheranostics, VP and chief medical officer at Roche Molecular Systems, and VP of pathology services at Genzyme Genetics.

Dugan received a BS in biology from the University of Notre Dame and a medical degree from the University of Arizona College of Medicine. He completed his post-graduate training in the department of pathology at Yale-New Haven Hospital and in the departments of pathology and laboratory medicine at Childrens Hospital Los Angeles and the University of California, Los Angeles.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.